A Registry Study of Biomarkers in Heart Valve Disease
ConditionCardiovascular Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorBeijing Institute of Heart, Lung and Blood Vessel Diseases
About this trial
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
Eligibility criteria
Qualifiers
Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital
Disqualifiers
Age < 18 years
Failure to obtain medical records and ultrasound data
Refuse follow-up
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov